The DOI matches its Crossref record; 345 of the 345 references it cites were found in a registry or an index.
The P2X7 Receptor Channel: Recent Developments and the Use of P2X7 Antagonists in Models of Disease
Open accessAbstract
The P2X7 receptor is a trimeric ATP-gated cation channel found predominantly, but not exclusively, on immune cells. P2X7 activation results in a number of downstream events, including the release of proinflammatory mediators and cell death and proliferation. As such, P2X7 plays important roles in various inflammatory, immune, neurologic and musculoskeletal disorders. This review focuses on the use of P2X7 antagonists in rodent models of neurologic disease and injury, inflammation, and musculoskeletal and other disorders. The cloning and characterization of human, rat, mouse, guinea pig, dog, and Rhesus macaque P2X7, as well as recent observations regarding the gating and permeability of P2X7, are discussed. Furthermore, this review discusses polymorphic and splice variants of P2X7, as well as the generation and use of P2X7 knockout mice. Recent evidence for emerging signaling pathways downstream of P2X7 activation and the growing list of negative and positive modulators of P2X7 activation and expression are also described. In addition, the use of P2X7 antagonists in numerous rodent models of disease is extensively summarized. Finally, the use of P2X7 antagonists in clinical trials in humans and future directions exploring P2X7 as a therapeutic target are described.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–345 of 345
Effect of the Purinergic Inhibitor Oxidized ATP in a Model of Islet Allograft Rejection
Vergani, A., Fotino, C., D’Addio, F., Tezza, S., Podetta, M., Gatti, F., Chin, M., Bassi, R., Molano, R. D., Corradi, D., et al. (2013) · Diabetes · doi:10.2337/db12-0242 · Cited by 87
Clemastine Potentiates the Human P2X7 Receptor by Sensitizing It to Lower ATP Concentrations
Nörenberg, W., Hempel, C., Urban, N. D., Sobottka, H., Illés, P., & Schaefer, M. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.198879 · Cited by 86
Chen, M., Cao, H., Chu, Y., Cheng, L., Liang, L., Zhang, Y., & Zhao, Z.-Q. (2012) · Journal of Pain · doi:10.1016/j.jpain.2012.06.007 · Cited by 86
Roger, S., Gillet, L., Baroja‐Mazo, A., Surprenant, A., & Pelegrín, P. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.053082 · Cited by 86
Sawynok, J., & Reid, A. R. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01001-7 · Cited by 85
Probenecid Blocks Human P2X7 Receptor-Induced Dye Uptake via a Pannexin-1 Independent Mechanism
Bhaskaracharya, A., Dao‐Ung, P., Jalilian, I., Spildrejorde, M., Skarratt, K. K., Fuller, S. J., Sluyter, R., & Stokes, L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0093058 · Cited by 83
Self-citationAntinociceptive effect of a new P2Z/P2X7 antagonist, oxidized ATP, in arthritic rats
DellʼAntonio, G., Quattrini, A., Cin, E. D., Fulgenzi, A., & Ferrero, M. E. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(02)00385-3 · Cited by 83
Jørgensen, N. R., Husted, L. B., Skarratt, K. K., Stokes, L., Tofteng, C. L., Kvist, T., Jensen, J. B., Eiken, P., Brixen, K., Fuller, S. J., et al. (2012) · European Journal of Human Genetics · doi:10.1038/ejhg.2011.253 · Cited by 82
Self-citationPremature Stop Codons Inactivate the RT6 Genes of the Human and Chimpanzee Species
Haag, F., Koch‐Nolte, F., Kühl, M., Lorenzen, S., & Thiele, H. (1994) · Journal of Molecular Biology · doi:10.1006/jmbi.1994.1680 · Cited by 82
Duplantier, A. J., Dombroski, M. A., Subramanyam, C., Beaulieu, A. M., Chang, S.-P., Gabel, C. A., Jordan, C. K., Kalgutkar, A. S. S., Kraus, K. G., Labasi, J. M., et al. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.04.077 · Cited by 81
Gu, B. J., Baird, P. N., Vessey, K. A., Skarratt, K. K., Fletcher, E. L., Fuller, S. J., Richardson, A. J., Guymer, R. H., & Wiley, J. S. (2013) · The FASEB Journal · doi:10.1096/fj.12-215368 · Cited by 81
P2X purinergic receptor ligands: recently patented compounds
Gunosewoyo, H., & Kassiou, M. (2010) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543771003702424 · Cited by 80
Broom, D. C., Matson, D. J., Bradshaw, E., Buck, M. E., Meade, R., Coombs, S. E., Matchett, M., Ford, K. K., Yu, W., Yuan, J., et al. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.141853 · Cited by 80
Taylor, S. R. J., González–Begne, M., Dewhurst, S., Chimini, G., Higgins, C. F., Melvin, J. E., & Elliott, J. I. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.1.300 · Cited by 79
Involvement of P2X receptor subtypes in ATP-induced enhancement of the cough reflex sensitivity
Kamei, J., Takahashi, Y., Yoshikawa, Y., & Saitoh, A. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.10.030 · Cited by 79
The Poly(ADP-ribose) polymerases (PARPs): New roles in intracellular transport
Elmageed, Z. Y. A., Naura, A. S., Errami, Y., & Zerfaoui, M. (2011) · Cellular Signalling · doi:10.1016/j.cellsig.2011.07.019 · Cited by 79
Chen, S., Ma, Q., Krafft, P. R., Chen, Y., Tang, J., Zhang, J., & Zhang, J. H. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e31829a8246 · Cited by 79
Xu, X. J., Boumechache, M., Robinson, L. E., Marschall, V., Górecki, D. C., Masin, M., & Murrell‐Lagnado, R. D. (2012) · Journal of Cell Science · doi:10.1242/jcs.099374 · Cited by 78
Sánchez‐Nogueiro, J., Marín‐García, P., & Miras‐Portugal, M. T. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.05.073 · Cited by 78
Riedel, T., Schmalzing, G., & Markwárdt, F. (2007) · Biophysical Journal · doi:10.1529/biophysj.106.103614 · Cited by 78
Gartland, A., Skarratt, K. K., Hocking, L. J., et al. (2012) · European Journal of Human Genetics · doi:10.1038/ejhg.2011.245 · Cited by 78
P2X7 receptor antagonism attenuates the hypertension and renal injury in Dahl salt-sensitive rats
Ji, X., Naito, Y., Hirokawa, G., Weng, H., Hiura, Y., Takahashi, R., & Iwai, N. (2011) · Hypertension Research · doi:10.1038/hr.2011.153 · Cited by 78
Calcium-dependent block of P2X7 receptor channel function is allosteric
Yan, Z., Khadra, A., Sherman, A., & Stojilković, S. S. (2011) · The Journal of General Physiology · doi:10.1085/jgp.201110647 · Cited by 76
Michel, A. D., Chambers, L. J., Clay, W. C., Condreay, J. P., WALTER, D. S., & Chessell, I. P. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707196 · Cited by 75
Friedle, S. A., Curet, M., & Watters, J. J. (2009) · Recent Patents on CNS Drug Discovery · doi:10.2174/157488910789753530 · Cited by 74
Kinetics of P2X7 Receptor-Operated Single Channels Currents
Riedel, T., Lozinsky, I. T., Schmalzing, G., & Markwárdt, F. (2006) · Biophysical Journal · doi:10.1529/biophysj.106.091413 · Cited by 72
Block of Purinergic P2X7R Inhibits Tumor Growth in a C6 Glioma Brain Tumor Animal Model
Ryu, J. K., Jantaratnotai, N., Serrano‐Pérez, M. C., McGeer, P. L., & McLarnon, J. G. (2010) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e318201d4d4 · Cited by 72
Complexities of Measuring Antagonist Potency at P2X7Receptor Orthologs
Hibell, A. D., Thompson, K. M., Xing, M., Humphrey, P. P. A., & Michel, A. D. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38838-x · Cited by 72
Schilling, W. P., Sinkins, W. G., & Estación, M. (1999) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1999.277.4.c755 · Cited by 72
Lenertz, L. Y., Gavala, M. L., Zhu, Y., & Bertics, P. J. (2011) · Immunologic Research · doi:10.1007/s12026-011-8203-4 · Cited by 71
Marcoli, M., Cervetto, C., Paluzzi, P., Guarnieri, S., Alloisio, S., Thellung, S., Nobile, M., & Maura, G. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05322.x · Cited by 70
Koch‐Nolte, F., Duffy, T., Nissen, M., et al. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.11.6014 · Cited by 70
Ichinari, K., Kakei, M., Matsuoka, T., Nakashima, H., & Tanaka, H. (1996) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1996.0179 · Cited by 70
P2X receptor characterization and IL‐1/IL‐1Ra release from human endothelial cells
Wilson, H. L., Varcoe, R. W., Stokes, L., Holland, K., Francis, S., Dower, S., Surprenant, A., & Crossman, D. C. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707213 · Cited by 69
Self-citationMotor neuron dysfunction in a mouse model of ALS: Gender-dependent effect of P2X7 antagonism
Cervetto, C., Frattaroli, D., Maura, G., & Marcoli, M. (2013) · Toxicology · doi:10.1016/j.tox.2013.04.004 · Cited by 67
Liu, X., Surprenant, A., Mao, H., Roger, S., Xia, R. M., Bradley, H., & Jiang, L. (2007) · Molecular Pharmacology · doi:10.1124/mol.107.039651 · Cited by 67
Jp, M., Silva, R. B. M., Coutinho‐Silva, R., Takiya, C. M., Battastini, A., Morrone, F. B., & Campos, M. M. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01535.x · Cited by 66
Michel, A. D., Clay, W. C., Ng, S., Roman, S. A., Thompson, K. M., Condreay, J. P., Hall, M. D., Holbrook, J. D., Livermore, D. G., & Senger, S. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.306 · Cited by 66
Lenertz, L. Y., Gavala, M. L., Hill, L. M., & Bertics, P. J. (2009) · Purinergic Signalling · doi:10.1007/s11302-009-9133-7 · Cited by 66
Kim, J.-E., Ryu, H. J., Yeo, S., & Kang, T. (2010) · Journal of Neuroinflammation · doi:10.1186/1742-2094-7-65 · Cited by 65
Xie, Y., Williams, C. D., McGill, M. R., Lebofsky, M., Ramachandran, A., & Jaeschke, H. (2012) · Toxicological Sciences · doi:10.1093/toxsci/kfs283 · Cited by 65
Hong, S., Schwarz, N., Braß, A., Séman, M., Haag, F., Koch‐Nolte, F., Schilling, W. P., & Dubyak, G. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900120 · Cited by 64
P2X receptor-dependent ATP-induced shedding of CD27 in mouse lymphocytes
Moon, H., NA, H., CHONG, K., & Kim, T. J. (2005) · Immunology Letters · doi:10.1016/j.imlet.2005.08.004 · Cited by 64
Dual Gating Mechanism and Function of P2X7 Receptor Channels
Khadra, A., Tomić, M., Yan, Z., Zemkova, H. W., Sherman, A., & Stojilković, S. S. (2013) · Biophysical Journal · doi:10.1016/j.bpj.2013.05.006 · Cited by 64
García-Huerta, P., Díaz-Hernández, M., Delicado, E. G., Pimentel-Santillana, M., Miras‐Portugal, M. T., & Gómez‐Villafuertes, R. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.390971 · Cited by 64
Subtype-specific control of P2X receptor channel signaling by ATP and Mg 2 +
Li, M., Silberberg, S. D., & Swartz, K. J. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1308088110 · Cited by 64
Adriouch, S., Ohlrogge, W., Haag, F., Koch‐Nolte, F., & Séman, M. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.1.196 · Cited by 64
Expression of P2X6 receptors in the enteric nervous system of the rat gastrointestinal tract
Yu, Q., Zhao, Z., Sun, J., Guo, W. M., Fu, J., Burnstock, G., He, C., & Xiang, Z. (2009) · Histochemistry and Cell Biology · doi:10.1007/s00418-009-0659-0 · Cited by 63
Regulation of AQP4 protein expression in rat brain astrocytes: Role of P2X7 receptor activation
Lee, M., Lee, S.-J., Choi, H., Jung, Y., Frøkiær, J., Nielsen, S. S., & Kwon, T. (2007) · Brain Research · doi:10.1016/j.brainres.2007.12.023 · Cited by 63
Yanagisawa, D., Kitamura, Y., Takata, K., Hide, I., Nakata, Y., & Taniguchi, A. T. (2008) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.31.1121 · Cited by 63
Schwarz, N., Drouot, L., Nicke, A., Fliegert, R., Boyer, O., Guse, A. H., Haag, F., Adriouch, S., & Koch‐Nolte, F. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041269 · Cited by 63
Young, C., Brutkowski, W., Lien, C., Arkle, S., Lochmüller, H., Zabłocki, K., & Górecki, D. C. (2011) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2011.01397.x · Cited by 63
Skarratt, K. K., Fuller, S. J., Sluyter, R., Dao‐Ung, L., Gu, B. J., & Wiley, J. S. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.03.091 · Cited by 63
Self-citationMechanism of action of species‐selective P2X7receptor antagonists
Michel, A. D., Ng, S., Roman, S. A., Clay, W. C., Dean, D. K., & Walter, D. S. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00135.x · Cited by 62
Chatterjee, S., Rana, R., Corbett, J. T., Kadiiska, M. B., Goldstein, J. A., & Mason, R. P. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.02.010 · Cited by 62
Portales‐Cervantes, L., Niño-Moreno, P., Doníz-Padilla, L., Baranda-Candido, L., García-Hernández, M. H., Salgado‐Bustamante, M., González‐Amaro, R., & Portales‐Pérez, D. P. (2010) · Human Immunology · doi:10.1016/j.humimm.2010.05.008 · Cited by 59
ATP, a partial agonist for the P2Z receptor of human lymphocytes
Gargett, C. E., Cornish, J. E., & Wiley, J. S. (1997) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701447 · Cited by 59
Novel P2X7 receptor antagonists
Alcaraz, L., Baxter, A., Bent, J., Bowers, K. C., Braddock, M., Cladingboel, D. E., Donald, D. K., Fagura, M., Furber, M., Laurent, C., et al. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2003.08.033 · Cited by 59
Non‐genomic inhibition of human P2X 7 purinoceptor by 17β‐oestradiol
Cario‐Toumaniantz, C., Loirand, G., Ferrier, L., & Pacaud, P. (1998) · The Journal of Physiology · doi:10.1111/j.1469-7793.1998.659bp.x · Cited by 58
Inhibition of P2X7 receptors by divalent cations: old action and new insight
Jiang, L. (2008) · European Biophysics Journal · doi:10.1007/s00249-008-0315-y · Cited by 58
Gidlöf, O., Smith, J. G., Melander, O., Lövkvist, H., Hedblad, B., Engström, G., Nilsson, P. M., Carlson, J. A., Berglund, G. L., Olsson, S., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037491 · Cited by 57
Bradley, H., Baldwin, J. M., Goli, G. R., Johnson, B., Zou, J., Sivaprasadarao, A., Baldwin, S. A., & Jiang, L. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.211284 · Cited by 56
Martin, U., Scholler, J., Gurgel, J. L., Renshaw, B. R., Sims, J. E., & Gabel, C. A. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803301 · Cited by 55
Feasibility study of B16 melanoma therapy using oxidized ATP to target purinergic receptor P2X7
Hattori, F., Ohshima, Y., Seki, S., Tsukimoto, M., Sato, M., Takenouchi, T., Suzuki, A., Takai, E., Kitani, H., Harada, H., et al. (2012) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2012.09.001 · Cited by 55
Itoh, K., Chiang, C., Li, Z., Lee, J., Dostrovsky, J. O., & Sessle, B. J. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.06.083 · Cited by 55
Lymphocytes from P2X7-deficient mice exhibit enhanced P2X7 responses
Taylor, S. R. J., González–Begne, M., Sojka, D. K., Richardson, J. C., Sheardown, S. A., Harrison, S. M., Pusey, C. D., Tam, F. W. K., & Elliott, J. I. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.0408251 · Cited by 53
Fang, K., Wang, Y., Huang, M., Sun, S. H., Cheng, H., & Tzeng, S. (2010) · Journal of Neuroscience Research · doi:10.1002/jnr.22538 · Cited by 53
Involvement of P2X and P2Y receptors in microglial activation in vivo
Franke, H., Schepper, C., Illés, P., & Krügel, U. (2007) · Purinergic Signalling · doi:10.1007/s11302-007-9082-y · Cited by 52
P2X7 receptor-mediated reactive oxygen and nitrogen species formation: from receptor to generators
Hewinson, J., & MacKenzie, A. B. (2007) · Biochemical Society Transactions · doi:10.1042/bst0351168 · Cited by 51
Chelerythrine and other benzophenanthridine alkaloids block the human P2X7 receptor
Shemon, A. N., Sluyter, R., Conigrave, A. D., et al. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705868 · Cited by 51
Self-citationSynthesis and Pharmacological Characterization of Two Novel, Brain Penetrating P2X7 Antagonists
Letavic, M. A., Lord, B., Bischoff, F., Hawryluk, N. A., Pieters, S., Rech, J. C., Sales, Z. S., Velter, A. I., Ao, H., Bonaventure, P., et al. (2013) · ACS Medicinal Chemistry Letters · doi:10.1021/ml400040v · Cited by 51
P2 receptor blockade attenuates fever and cytokine responses induced by lipopolysaccharide in rats
Gourine, A. V., Poputnikov, D. M., Zhernosek, N., Melenchuk, E. V., Gerstberger, R., Spyer, K. M., & Gourine, V. N. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706287 · Cited by 49
Teixeira, J. M., Oliveira, M. C. G., Nociti, F. H., et al. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.06.008 · Cited by 49
Welter-Stahl, L., Marques-da-Silva, C., Schachter, J., Persechini, P. M., de Souza, H. S. P., Ojcius, D. M., & Coutinho‐Silva, R. (2009) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2009.03.006 · Cited by 48
Verkhratsky, A., Pankratov, Y. V., Lalo, U., & Nedergaard, M. (2012) · Wiley Interdisciplinary Reviews Membrane Transport and Signalling · doi:10.1002/wmts.12 · Cited by 48
Tu, G., Li, G., Peng, H., Hu, J., Liu, J., Kong, F., Liu, S., Gao, Y., Xu, C., Xu, X., et al. (2013) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2013.05.004 · Cited by 48
Inhibition of ATP-induced macrophage death by emodin via antagonizing P2X7 receptor
Liu, L., Zou, J., Liu, X., Jiang, L., & Li, J. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.04.036 · Cited by 48
Identification of Thr283 as a key determinant of P2X7 receptor function
Young, M. T., Pelegrín, P., & Surprenant, A. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706880 · Cited by 48
Wiley, J. S., & Gu, B. J. (2012) · Purinergic Signalling · doi:10.1007/s11302-012-9308-5 · Cited by 47
Perez‐Medrano, A., Donnelly‐Roberts, D. L., Honoré, P., Hsieh, G. C., Namovic, M. T., Peddi, S., Shuai, Q., Wang, Y., Faltynek, C. R., Jarvis, M. F., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm8015848 · Cited by 47
P2X7 receptor activation induces reactive oxygen species formation in erythroid cells
Wang, B., & Sluyter, R. (2012) · Purinergic Signalling · doi:10.1007/s11302-012-9335-2 · Cited by 46
Self-citationEffect of P2X4 and P2X7 receptor antagonism on the pressure diuresis relationship in rats
Menzies, R. I., Unwin, R. J., Dash, R. K., et al. (2013) · Frontiers in Physiology · doi:10.3389/fphys.2013.00305 · Cited by 45
Kim, J., Ryu, H. J., & Kang, T. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-62 · Cited by 45
P2X7 receptor gene polymorphism analysis in rheumatoid arthritis
Al-Shukaili, A. K., Alkaabi, J., Hassan, B., Al‐Araimi, T., Tobi, M. A., Al-Kindi, M., Al-Maniri, A., Al-Gheilani, A., & Al-Ansari, A. (2011) · International Journal of Immunogenetics · doi:10.1111/j.1744-313x.2011.01019.x · Cited by 43
Gavala, M. L., Hill, L. M., Lenertz, L. Y., Karta, M. R., & Bertics, P. J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.142091 · Cited by 42
Agonist potency at P2X7 receptors is modulated by structurally diverse lipids
Michel, A. D., & Fonfría, E. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707417 · Cited by 42
Liu, J., Li, G., Peng, H., Tu, G., Kong, F., Liu, S., Gao, Y., Xu, H., Qiu, S., Fan, B., et al. (2013) · Purinergic Signalling · doi:10.1007/s11302-013-9367-2 · Cited by 42
Zhu, S., Wang, Y., Wang, X., Li, J., & Hu, F. Z. (2013) · Pharmaceutical Biology · doi:10.3109/13880209.2013.810648 · Cited by 41
Hempel, C., Nörenberg, W., Sobottka, H., Urban, N. D., Nicke, A., Fischer, W., & Schaefer, M. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.07.027 · Cited by 41
Savigni, D. L., Doig, R. O., Szymanski, C. R., Bartlett, C. A., Lozić, I., Smith, N. M., & Fitzgerald, M. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.07.034 · Cited by 41
Oxidized ATP inhibits T‐cell‐mediated autoimmunity
Lang, P. A., Merkler, D., Funkner, P., Shaabani, N., Meryk, A., Krings, C., Barthuber, C., Recher, M., Brück, W., Häussinger, D., et al. (2010) · European Journal of Immunology · doi:10.1002/eji.200939838 · Cited by 40
Marcillo, A. E., Frydel, B. R., Bramlett, H. M., & Dietrich, W. D. (2011) · Experimental Neurology · doi:10.1016/j.expneurol.2011.06.008 · Cited by 40
Csölle, C., & Sperlágh, B. (2009) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2009.11.011 · Cited by 39
Point Mutation in the Mouse P2X 7 Receptor Affects Intercellular Calcium Waves in Astrocytes
Suadicani, S. O., Iglesias, R., Spray, D. C., & Scemes, E. (2009) · ASN NEURO · doi:10.1042/an20090001 · Cited by 38
Sluyter, R., Shemon, A. N., Hughes, W. E., Stevenson, R. O., Georgiou, J. G., Eslick, G. D., Taylor, R. M., & Wiley, J. S. (2007) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00166.2007 · Cited by 38
Self-citationTwo open states of P2X receptor channels
Rokic, M. B., & Stojilković, S. S. (2013) · Frontiers in Human Neuroscience · doi:10.3389/fncel.2013.00215 · Cited by 36
Westlund, K. N., Zhang, L., Ma, F., & Oz, H. S. (2011) · Translational research · doi:10.1016/j.trsl.2011.10.003 · Cited by 35
The Effects of General Anesthetics on P2X7 and P2Y Receptors in a Rat Microglial Cell Line
Nakanishi, M., Mori, T., Nishikawa, K., Sawada, M., Kuno, M., & Asada, A. (2007) · Anesthesia & Analgesia · doi:10.1213/01.ane.0000260615.12553.4e · Cited by 34
Gavala, M. L., Pfeiffer, Z. A., & Bertics, P. J. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.0907612 · Cited by 34
Pharmacological properties of the rhesus macaque monkey P2X7 receptor
Bradley, H., Browne, L. E., Yang, W., & Jiang, L. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01399.x · Cited by 33
Ito, G., Suekawa, Y., Watanabe, M., Takahashi, K., Inubushi, T., Murasaki, K., Hirose, N., Hiyama, S., Uchida, T., & Tanne, K. (2012) · European Journal of Pain · doi:10.1002/j.1532-2149.2012.00174.x · Cited by 33
Fulgenzi, A., DellʼAntonio, G., Foglieni, C., Cin, E. D., Ticozzi, P., Franzone, J. S., & Ferrero, M. E. (2005) · BMC Immunology · doi:10.1186/1471-2172-6-18 · Cited by 33
Teixeira, J. M., Oliveira, M. C. G., Parada, C. A., & Tambeli, C. H. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.06.061 · Cited by 33
Cloning and pharmacological characterization of the guinea pig P2X7receptor orthologue
Fonfría, E., Clay, W. C., Levy, D. S., Goodwin, J. A., Roman, S. A., Smith, G. D., Condreay, J. P., & Michel, A. D. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707596 · Cited by 32
Anti-Prion Activity of Brilliant Blue G
Iwamaru, Y., Takenouchi, T., Murayama, Y., Okada, H., Imamura, M., Shimizu, Y., Hashimoto, M., Mohri, S., Yokoyama, T., & Kitani, H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037896 · Cited by 32
Stevenson, R. O., Taylor, R. M., Wiley, J. S., & Sluyter, R. (2009) · Purinergic Signalling · doi:10.1007/s11302-009-9163-1 · Cited by 32
Self-citationPharmacological properties of a pore induced by raising intracellular Ca2+
Faria, R. X., Reis, R. A. D. M., Casabulho, C. M., Alberto, A. V. P., de Farias, F. P., Henriques‐Pons, A., & Alves, L. A. (2009) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00476.2008 · Cited by 31
Identification of 2-oxo-N-(phenylmethyl)-4-imidazolidinecarboxamide antagonists of the P2X7 receptor
Abberley, L., Bebius, A., Beswick, P., Billinton, A., Collis, K. L., Dean, D. K., Fonfría, E., Gleave, R. J., Medhurst, S. J., Michel, A. D., et al. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.09.101 · Cited by 31
Lu, Y.-M., Tao, R.-R., Huang, J.-Y., Li, L.-T., Liao, M.-H., Li, X. M., Fukunaga, K., Hong, Z.-H., & Han, F. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-172 · Cited by 31
Cloning and pharmacological characterization of the dog P2X7 receptor
Roman, S. A., Cusdin, F., Fonfría, E., Goodwin, J. A., Reeves, J. J., Lappin, S. C., Chambers, L. J., WALTER, D. S., Clay, W., & Michel, A. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00425.x · Cited by 30
Chiao, C.-W., da Silva‐Santos, J. E., Giachini, F. R. C., Tostes, R. C., Su, M., & Webb, R. C. (2013) · Clinical Science · doi:10.1042/cs20120479 · Cited by 30
Gu, B. J., Duce, J. A., Valova, V. A., Wong, B. X. W., Bush, A. I., Petrou, S., & Wiley, J. S. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.340885 · Cited by 30
Hassler, M., & Ladurner, A. G. (2012) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2012.08.005 · Cited by 30
The P2X7 receptor as a route for non‐exocytotic glutamate release: dependence on the carboxyl tail
Cervetto, C., Alloisio, S., Frattaroli, D., Mazzotta, M. C., Milanese, M., Gavazzo, P., Passalacqua, M., Nobile, M., Maura, G., & Marcoli, M. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12143 · Cited by 29
da Silva, G. L., Sperotto, N. D. D. M., Borges, T. J., Bonorino, C., Takyia, C. M., Coutinho‐Silva, R., Campos, M. M., Zanin, R. F., & Morrone, F. B. (2013) · Experimental Dermatology · doi:10.1111/exd.12094 · Cited by 29
Association between P2X7 Receptor Polymorphisms and Bone Status in Mice
Syberg, S., Schwarz, P., Petersen, S., Steinberg, T. H., Jensen, J. B., Teilmann, J., & Jørgensen, N. R. (2012) · Journal of Osteoporosis · doi:10.1155/2012/637986 · Cited by 29
Fulgenzi, A., Ticozzi, P., Gabel, C. A., DellʼAntonio, G., Quattrini, A., Franzone, J. S., & Ferrero, M. E. (2008) · International Journal of Immunopathology and Pharmacology · doi:10.1177/039463200802100108 · Cited by 29
Analysis of a polymorphic microRNA target site in the purinergic receptor P2RX7 gene
Rahman, O. A., Sasvari‐Szekely, M., Szekely, A., Faludi, G., Guttman, A., & Nemoda, Z. (2010) · ELECTROPHORESIS · doi:10.1002/elps.200900664 · Cited by 28
Sugiyama, T., Lee, S. Y., Horie, T., Oku, H., Takai, S., Tanioka, H., Kuriki, Y., Kojima, S., & Ikeda, T. (2013) · Europe PMC (PubMed Central) · Cited by 28
Lemaire, I. B., & Leduc, N. (2003) · Drug Development Research · doi:10.1002/ddr.10209 · Cited by 27
Kang, S. S., Keasey, M. P., & Hagg, T. (2013) · Translational Stroke Research · doi:10.1007/s12975-013-0265-2 · Cited by 27
Human P2X7 receptor activation induces the rapid shedding of CXCL16
Pupovac, A., Foster, C. M., & Sluyter, R. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.01.134 · Cited by 27
Self-citationNiphatoxin C, a Cytotoxic Tripyridine Alkaloid from Callyspongia sp.
Buchanan, M. S., Carroll, A. R., Addepalli, R., Avery, V. M., Hooper, J. N. A., & Quinn, R. J. (2007) · Journal of Natural Products · doi:10.1021/np070366q · Cited by 27
Jalilian, I., Peranec, M., Curtis, B. L., Seavers, A., Spildrejorde, M., Sluyter, V., & Sluyter, R. (2012) · Veterinary Immunology and Immunopathology · doi:10.1016/j.vetimm.2012.05.004 · Cited by 26
Self-citationP2X receptor-mediated ATP purinergic signaling in health and disease
Jiang, L. (2012) · Cell Health and Cytoskeleton · doi:10.2147/chc.s27196 · Cited by 26
Lester, S. E., Stokes, L., Skarratt, K. K., Gu, B. J., Sivils, K. L. M., Lessard, C. J., Wiley, J. S., & Rischmueller, M. (2013) · Arthritis Research & Therapy · doi:10.1186/ar4248 · Cited by 25
Self-citationMichel, A. D., Thompson, K. M., Simon, J., et al. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706938 · Cited by 24
Overexpression of CD39 in Mouse Airways Promotes Bacteria-Induced Inflammation
Théâtre, E., Frederix, K., Guilmain, W., Delierneux, C., Lecut, C., Bettendorff, L., Bours, V., & Oury, C. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1102600 · Cited by 24
Seil, M., Fontanils, U., Gorroño, I., Pochet, S., Garcia‐Marcos, M., Marino, A., & Dehaye, J. (2008) · Purinergic Signalling · doi:10.1007/s11302-008-9118-y · Cited by 23
McHugh, S. M., Roman, S. A., Davis, B. G., Koch, A., Pickett, A. M., Richardson, J. C., Miller, S. R., Wetten, S., Cox, C. J., Karpe, F., et al. (2012) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2012.04200.x · Cited by 23
Shemon, A. N., Sluyter, R., & Wiley, J. S. (2006) · Immunology and Cell Biology · doi:10.1038/sj.icb.7100005 · Cited by 23
Self-citationLi, C. M., Campbell, S. J., Kumararatne, D. S., Hill, A. V. S., & Lammas, D. A. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)03424-5 · Cited by 22
Regulation by CRAMP of the responses of murine peritoneal macrophages to extracellular ATP
Seil, M., Kabré, E., Nagant, C., Vandenbranden, M., Fontanils, U., Marino, A., Pochet, S., & Dehaye, J. (2009) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2009.11.002 · Cited by 21
P2X7 receptors contribute to the currents induced by ATP in guinea pig intestinal myenteric neurons
Valdez-Moráles, E. E., Alba, R. G., Liñán-Rico, A., Espinosa‐Luna, R., Zarazúa, S., Miranda‐Morales, M., Montaño, L. M., & Barajas‐López, C. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.07.019 · Cited by 20
Pharmacologic P2X purinergic receptor antagonism in the treatment of collagen-induced arthritis.
Ardissone, V., Radaelli, E., Zaratin, P., Ardizzone, M., Ladel, C., Gattorno, M., Martini, A., Grassi, F., & Traggiai, E. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30556 · Cited by 20
The Physiology, Pharmacology and Future of P2X7 as An Analgesic Drug Target: Hype or Promise?
Bhattacharya, A., Neff, R. A., & Wickenden, A. D. (2011) · Current Pharmaceutical Biotechnology · doi:10.2174/138920111798357429 · Cited by 20
Jalilian, I., Spildrejorde, M., Seavers, A., Curtis, B. L., McArthur, J. D., & Sluyter, R. (2012) · Veterinary Immunology and Immunopathology · doi:10.1016/j.vetimm.2012.09.040 · Cited by 18
Self-citationInhibition of the human P2X7 receptor by a novel protein tyrosine kinase antagonist
Shemon, A. N., Sluyter, R., Stokes, L., et al. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.11.008 · Cited by 15
Self-citationOuaaliti, M. E., Seil, M., & Dehaye, J. (2012) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2012.09.005 · Cited by 13
Defective T-Lymphocyte Migration to Muscles in Dystrophin-Deficient Mice
Cascabulho, C. M., Corrêa, C. B., Cotta-de-Almeida, V., & Henriques‐Pons, A. (2012) · American Journal Of Pathology · doi:10.1016/j.ajpath.2012.04.023 · Cited by 13
Franke, H., Krügel, U., Grosche, J., & Illés, P. (2003) · Drug Development Research · doi:10.1002/ddr.10216 · Cited by 11
Extracellular ATP induces CD44 shedding from macrophage‐like P388D1 cells via the P2X7 receptor
Lin, C., Ren, S., Zhang, L., Jin, H., Sun, J., & Zuo, Y. (2011) · Hematological Oncology · doi:10.1002/hon.1008 · Cited by 10
Zhou, Z.-H., Wang, J., Liu, B., Li, M., Lu, Y., & Chen, D. (2012) · Neuroscience Letters · doi:10.1016/j.neulet.2012.10.040 · Cited by 5
What Have We Learned about the Pathogenesis of Rheumatoid Arthritis from TNF-Targeted Therapy?
Williams, R. O. (2012) · ISRN Immunology · doi:10.5402/2012/652739 · Cited by 5
Biologics: the next-generation therapeutics for analgesia?
Hatcher, J. P., Chessell, I. P., & Hughes, J. P. (2011) · Expert Review of Neurotherapeutics · doi:10.1586/ern.11.66 · Cited by 5
Cited by
DAMP-sensing receptors in sterile inflammation and inflammatory diseases
Gong, T., Liu, L., Jiang, W., & Zhou, R. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-019-0215-7 · Cited by 1,672
The P2X7 Receptor in Infection and Inflammation
Di Virgilio, F., Dal Ben, D., Sarti, A. C., Giuliani, A. L., & Falzoni, S. (2017) · Immunity · doi:10.1016/j.immuni.2017.06.020 · Cited by 1,267
Ion Channels in Innate and Adaptive Immunity
Feske, S., Wulff, H., & Skolnik, E. Y. (2015) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032414-112212 · Cited by 768
Yang, D., He, Y., Muñoz-Planillo, R., Liu, Q., & Núñez, G. (2015) · Immunity · doi:10.1016/j.immuni.2015.10.009 · Cited by 596
Purinergic Signalling: Therapeutic Developments
Burnstock, G. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00661 · Cited by 398
Metadata
- Authors
- Bartlett, R., Stokes, L., & Sluyter, R.
- Venue
- Pharmacological Reviews
- Publisher
- Elsevier BV
- Published
- 2014-07
- Volume
- 66
- Issue
- 3
- Pages
- 638-675
- ISSN
- 0031-6997 (ISSN-L)
- OpenAlex
- W2128767149
- Cited by
- 393
- References
- 345
- FWCI
- 28.74
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.